Gao Yadi, Yuan Weichen, Zhang Jiexiang, Wang Zhiwei, Cui Wenwen, Guan Zhongan
The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Hum Vaccin Immunother. 2025 Dec;21(1):2512656. doi: 10.1080/21645515.2025.2512656. Epub 2025 Jul 14.
Tumor-associated macrophages (TAMs), the predominant immune cells in the tumor microenvironment (TME), facilitate proliferation, invasion, metastasis, angiogenesis, chemoresistance, and immunosuppression in colorectal cancer (CRC). The mutual pathological mechanisms remain unclear, necessitating an in-depth study of the relationship between TAMs and CRC. This paper employs bibliometric methods to analyze TAMs and CRC research literature, aiming to assess current trends, evaluate the research status, and forecast future directions and emerging topics. We searched for publications published in the Web of Science Core Collection (WOSCC) database from January 1, 2001 to July 31, 2024. Following the establishment of specific search criteria for time, publication type, and language, bibliometric analysis and data visualization were conducted using Microsoft Excel, R software, VOSviewer, and CiteSpace. A total of 1,218 publications authored by 8,302 researchers across 61 countries and 1,657 institutions were analyzed. They were published in 427 journals, covering 4,451 keywords and citing 65,174 references. Keyword co-occurrence and literature co-citation analysis identified nuclear factor kappa-B, endothelial growth factor, angiogenesis, polarization, TME, immune response, programmed cell death protein 1 blockade, and metabolism as current research hotspots and trends in this field. Immune therapy and cancer-associated fibroblasts are key research areas, with the potential for further exploration of their mechanisms and targeted therapies. This paper employs bibliometric methods to comprehensively analyze and visualize research papers in TAMs and CRC. It analyzes the TAM-targeting research landscape in CRC, mapping current frontiers and translational potential to position TAMs as a promising immunotherapeutic strategy.
肿瘤相关巨噬细胞(TAMs)是肿瘤微环境(TME)中的主要免疫细胞,可促进结直肠癌(CRC)的增殖、侵袭、转移、血管生成、化疗耐药和免疫抑制。其相互的病理机制尚不清楚,因此有必要深入研究TAMs与CRC之间的关系。本文采用文献计量学方法分析TAMs与CRC的研究文献,旨在评估当前趋势、评价研究现状,并预测未来方向和新兴主题。我们检索了Web of Science核心合集(WOSCC)数据库中2001年1月1日至2024年7月31日发表的文献。在确定了时间、出版类型和语言的具体检索标准后,使用Microsoft Excel、R软件、VOSviewer和CiteSpace进行文献计量分析和数据可视化。共分析了来自61个国家的8302名研究人员和1657个机构撰写的1218篇文献。这些文献发表在427种期刊上,涵盖4451个关键词,并引用了65174篇参考文献。关键词共现和文献共被引分析确定核因子κB、内皮生长因子、血管生成、极化、TME、免疫反应、程序性细胞死亡蛋白1阻断和代谢是该领域当前的研究热点和趋势。免疫治疗和癌症相关成纤维细胞是关键研究领域,有进一步探索其机制和靶向治疗的潜力。本文采用文献计量学方法对TAMs与CRC的研究论文进行全面分析和可视化。它分析了CRC中靶向TAM的研究格局,绘制了当前前沿和转化潜力,将TAMs定位为一种有前景的免疫治疗策略。
Hum Vaccin Immunother. 2025-12
Front Oncol. 2025-6-30
J Cancer Res Clin Oncol. 2024-11-15
Exp Hematol Oncol. 2024-7-16
Lancet. 2024-7-20
Ann Intern Med. 2024-4
Front Immunol. 2023